Clinical outcomes and pathogenetic mechanisms of adjunctive ribonucleic acid therapy in adult patients with measles during the period of increased incidence in 2025–2026. (2026). Infectious Diseases – Infektsiyni Khvoroby, 3, 13-26. https://doi.org/10.11603/1681-2727.2026.3.16753